Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial | Zendy

Cendrine Godet | Zendy; Françis Couturaud | Zendy; S. MarchandAdam | Zendy; Christophe Pison | Zendy; Frédéric Gagnadoux | Zendy; Élodie Blanchard | Zendy; Camille Taillé | Zendy; Bruno Philippe | Zendy; Sandrine Hirschi | Zendy; Claire Andréjak | Zendy; Arnaud Bourdin | Zendy; Cécile Chenivesse | Zendy; S. Dominique | Zendy; Laurence Bassinet | Zendy; M. MurrisEspin | Zendy; F. Rivière | Zendy; Gilles Garcia | Zendy; D. Caillaud | Zendy; F.–X. Blanc | Zendy; François Goupil | Zendy; Anne Bergeron | Zendy; Anne Gondouin | Zendy; JeanPierre Frat | Zendy; Thomas Flament | Zendy; B. Camara | Zendy; Pascaline Priou | Zendy; AnneLaure Brun | Zendy; François Laurent | Zendy; Stéphanie Ragot | Zendy; J. Cadranel | Zendy; J.-P. Frat | Zendy; A-L. Brun | Zendy; Philippe Bouvet | Zendy; L. Bassinet | Zendy

Open Access

Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial

Author(s) -

Cendrine Godet,

Françis Couturaud,

S. MarchandAdam,

Christophe Pison,

Frédéric Gagnadoux,

Élodie Blanchard,

Camille Taillé,

Bruno Philippe,

Sandrine Hirschi,

Claire Andréjak,

Arnaud Bourdin,

Cécile Chenivesse,

S. Dominique,

Laurence Bassinet,

M. MurrisEspin,

F. Rivière,

Gilles Garcia,

D. Caillaud,

F.–X. Blanc,

François Goupil,

Anne Bergeron,

Anne Gondouin,

JeanPierre Frat,

Thomas Flament,

B. Camara,

Pascaline Priou,

AnneLaure Brun,

François Laurent,

Stéphanie Ragot,

J. Cadranel,

J.-P. Frat,

A-L. Brun,

Philippe Bouvet,

L. Bassinet

Publication year - 2021

Publication title -

european respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.021

H-Index - 241

eISSN - 1399-3003

pISSN - 0903-1936

DOI - 10.1183/13993003.02218-2021

Subject(s) - medicine , exacerbation , amphotericin b , allergic bronchopulmonary aspergillosis , clinical trial , randomized controlled trial , interquartile range , group b , placebo , aspergillosis , surgery , immunology , immunoglobulin e , antifungal , dermatology , alternative medicine , antibody , pathology

In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog